(Q38238940)

31 August 2017

title

The link between multiple sclerosis and depression (English)

1 reference

31 August 2017

0 references

Anthony Feinstein

1

1 reference

31 August 2017

Sandra Magalhaes

2

1 reference

31 August 2017

Jean-Francois Richard

3

1 reference

31 August 2017

Blair Audet

4

1 reference

31 August 2017

Craig Moore

5

1 reference

31 August 2017

language of work or name

English

0 references

publication date

12 August 2014

1 reference

31 August 2017

published in

Nature Reviews Neurology

1 reference

31 August 2017

volume

10

1 reference

31 August 2017

issue

9

1 reference

31 August 2017

page(s)

507-517

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneurol.2014.139

31 August 2017

exact match

0 references

cites work

Evidence-based guideline: assessment and management of psychiatric disorders in individuals with MS: report of the Guideline Development Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

The hospital anxiety and depression scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Screening for depression among patients with multiple sclerosis: two questions may be enough

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

The PHQ-9: validity of a brief depression severity measure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Comparing CESD-10, PHQ-9, and PROMIS depression instruments in individuals with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Depression and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 surveys' estimates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Major depression in multiple sclerosis: a population-based perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

A large-scale study of anxiety and depression in people with Multiple Sclerosis: a survey via the web portal of the UK MS Register

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Gender differences in depression and anxiety across the adult lifespan: the role of psychosocial mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Anxiety and depression in multiple sclerosis. A comparative population-based study in Nord-Trøndelag County, Norway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Neuropsychological aspects of childhood multiple sclerosis: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Acute optic neuritis. A cognitive and magnetic resonance imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Clinically isolated lesions of the type seen in multiple sclerosis: a cognitive, psychiatric, and MRI follow up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

The association of depression with disease course in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Hopelessness ratings in relapsing-remitting and secondary progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Longitudinal course of depression symptoms in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Mood and coping in clinically isolated syndrome and multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Multiple sclerosis relapses and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Pain associated with multiple sclerosis: systematic review and proposed classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

The co-occurrence of pain and depression in adults with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Reciprocal relationship between pain and depression: a 12-month longitudinal analysis in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Behavioral interventions in multiple sclerosis: a biopsychosocial perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Anxiety disorders and their clinical correlates in multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Social anxiety in a multiple sclerosis clinic population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Anxiety and depression in multiple sclerosis patients around diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Prospective examination of anxiety and depression before and during confirmed and pseudoexacerbations in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Symptom overlap in anxiety and multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Factors affecting anxiety in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Multiple sclerosis and alcohol: a study of problem drinking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Anxiety state affects information processing speed in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Epidemiology of chronic and nonchronic major depressive disorder: results from the national epidemiologic survey on alcohol and related conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Alcohol and drug abuse among persons with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

The association of alcohol consumption and smoking with quality of life, disability and disease activity in an international sample of people with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Cognitive improvement with treatment of depression following mild traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Decreased hippocampal volume, indirectly measured, is associated with depressive symptoms and consolidation deficits in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

ApoE alleles, depression and positive affect in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Lesions in the left arcuate fasciculus region and depressive symptoms in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Beck Depression Inventory factors related to demyelinating lesions of the left arcuate fasciculus region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Structural brain abnormalities in multiple sclerosis patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Depressive symptoms and MRI changes in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Diffusion tensor imaging abnormalities in depressed multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Circadian cortisol, depressive symptoms and neurological impairment in early multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Smaller cornu ammonis 2-3/dentate gyrus volumes and elevated cortisol in multiple sclerosis patients with depressive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Impaired hypothalamic-pituitary-adrenal axis activity in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

HPA axis activity in multiple sclerosis correlates with disease severity, lesion type and gene expression in normal-appearing white matter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: association with cerebral inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Detection of altered hippocampal morphology in multiple sclerosis-associated depression using automated surface mesh modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Involvement of the limbic system in multiple sclerosis patients with depressive disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Neurobiological mechanisms underlying emotional processing in relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Role of immunological factors in the pathophysiology and diagnosis of bipolar disorder: comparison with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Inflammation and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Elevated specific peripheral cytokines found in major depressive disorder patients with childhood trauma exposure: a cytokine antibody array analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Susceptibility of the adolescent brain to cannabinoids: long-term hippocampal effects and relevance to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Depression and immunity: inflammation and depressive symptoms in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Association of major depressive disorder with serum myeloperoxidase and other markers of inflammation: a twin study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

The role of inflammatory cytokines in suicidal behavior: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Serum concentrations of CRP, IL-6, TNF-α and cortisol in major depressive disorder with melancholic or atypical features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Tryptophan depletion in depressed patients occurs independent of kynurenine pathway activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Systemic tumor necrosis factor-alpha decreases brain stimulation reward and increases metabolites of serotonin and dopamine in the nucleus accumbens of mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Endocrine and immune substrates of depressive symptoms and fatigue in multiple sclerosis patients with comorbid major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Stimulated peripheral production of interferon-gamma is related to fatigue and depression in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Altered cognitive-emotional behavior in early experimental autoimmune encephalitis--cytokine and hormonal correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Inflammation modulates anxiety in an animal model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

TNF-α-mediated anxiety in a mouse model of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

The EAE-associated behavioral syndrome: II. Modulation by anti-inflammatory treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

A prospective study of depression and immune dysregulation in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

The relationship between depression and interferon beta-1a therapy in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Oral fingolimod (FTY720) in relapsing multiple sclerosis: impact on health-related quality of life in a phase II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

The relationship between disability and depression in multiple sclerosis: the role of uncertainty, coping, and hope

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

The role of helplessness as mediator between neurological disability, emotional instability, experienced fatigue and depression in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Contributing factors to depressed mood in Multiple Sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Predictors of dyadic adjustment in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

The effects of economic disadvantage on psychological well-being and quality of life among people with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Coping strategies, cognitive impairment, psychological variables and their relationship with quality of life in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Cumulative impact of comorbidity on quality of life in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

An examination of suicidal intent in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Cause of death in patients attending multiple sclerosis clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Suicide and patients with neurologic diseases. Methodologic problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Treatment of depression for patients with multiple sclerosis in neurology clinics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Increased rate of treatment with antidepressants in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Efficacy of paroxetine in treating major depressive disorder in persons with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Duloxetine is effective in treating depression in multiple sclerosis patients: an open-label multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Moclobemide treatment in multiple sclerosis patients with comorbid depression: an open-label safety trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Brain lesion volume and neuropsychological function predict efficacy of treatment for depression in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Cognitive behaviour therapy for common mental disorders in people with Multiple Sclerosis: A bench marking study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Association between brain-derived neurotrophic factor genetic polymorphism Val66Met and susceptibility to bipolar disorder: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

MS quality of life, depression, and fatigue improve after mindfulness training: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

A randomized trial of stress management for the prevention of new brain lesions in MS

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Exercising away the blues: can it help multiple sclerosis-related depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Transcranial magnetic stimulation for the treatment of depression in neurologic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Electroconvulsive therapy in patient with psychotic depression and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Electroconvulsive therapy in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Multiple sclerosis and ECT: possible value of gadolinium-enhanced magnetic resonance scans for identifying high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Comparative assessment of Yale Single Question and Beck Depression Inventory Scale in screening for depression in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Increased depression in multiple sclerosis patients. A meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

A longitudinal analysis of cognitive dysfunction, coping, and depression in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Chronic pain in a large community sample of persons with multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Depression in multiple sclerosis: relationship to planning ability

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Personal and family history of affective illness in patients with multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Depression in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Multiple sclerosis and affective disorder. Family history, sex, and HLA-DR antigens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Brain MRI lesions and atrophy are related to depression in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Lesion pattern in patients with multiple sclerosis and depression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Cytokine imbalance in the pathophysiology of major depressive disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Multiple sclerosis, interferon beta-1b and depression A prospective investigation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Depression in multiple sclerosis: review and theoretical proposal

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Factors associated with health-related quality of life in multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Antidepressant use in multiple sclerosis: epidemiologic study of a large community sample

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Pharmacologic treatment of depression in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

The effect of fluoxetine in depression associated with multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Tranylcypromine in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Cognitive predictors of response to treatment for depression in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

Psychological interventions for multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

The acceptability of computerised cognitive behavioural therapy for the treatment of depression in people with chronic physical disease: A qualitative study of people with multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.139

The effects of anxiety on psychiatric morbidity in patients with multiple sclerosis.

31 March 2020

1 reference

12 December 2020

Cytokines and late-life depression.

1 reference

12 December 2020

Fatigue in multiple sclerosis: relationship to depression, disability, and disease pattern.

1 reference

12 December 2020

Depressed mood in multiple sclerosis: relationship to capacity-demanding memory and attentional functioning

1 reference

12 December 2020

Moderating effects of coping on the relationship between stress and the development of new brain lesions in multiple sclerosis

1 reference

12 December 2020

Psychiatric morbidity in multiple sclerosis: a clinical and MRI study.

1 reference

12 December 2020

[Processing speed in relapsing-remitting multiple sclerosis: the role played by the depressive symptoms]

1 reference

12 December 2020

Telephone-administered cognitive-behavioral therapy for the treatment of depressive symptoms in multiple sclerosis

1 reference

12 December 2020

A double-blind trial with an antidepressant drug, imipramine, in multiple sclerosis

1 reference

12 December 2020

Biopsychosocial correlates of lifetime major depression in a multiple sclerosis population

1 reference

12 December 2020

Measurement of treatment response to sertraline in depressed multiple sclerosis patients using the Carroll scale.

1 reference

12 December 2020

The risk of developing depression when suffering from neurological diseases

1 reference

12 December 2020

Antidepressant pharmacotherapy of depression associated with multiple sclerosis

1 reference

12 December 2020

Cognitive behavioural therapy for the treatment of depression in people with multiple sclerosis: a systematic review and meta-analysis

1 reference

12 December 2020

Depression in multiple sclerosis: relationship to working memory capacity.

1 reference

12 December 2020

10.1038/NRNEUROL.2014.139

Identifiers

DOI

1 reference

Dimensions Publication ID

31 August 2017

1048897091

0 references

1 reference